{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T23:50:49Z","timestamp":1777679449706,"version":"3.51.4"},"reference-count":15,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2026,3,13]]},"DOI":"10.7759\/cureus.105194","type":"journal-article","created":{"date-parts":[[2026,3,14]],"date-time":"2026-03-14T03:31:31Z","timestamp":1773459091000},"source":"Crossref","is-referenced-by-count":1,"title":["Therapeutic Plasma Exchange for Severe Exogenous Thyrotoxicosis Following Massive Levothyroxine Ingestion: A Case Report"],"prefix":"10.7759","author":[{"given":"Anas","family":"Kartoumah","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Adam","family":"Abow Alkhier","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Laith","family":"Kabbani","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Noah","family":"Baranski","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Muaz","family":"Mallah","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mohanad","family":"Horani","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mohamad","family":"Horani","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.1089\/thy.2016.0229","article-title":"2016 American Thyroid Association guidelines for diagnosis and management of hyperthyroidism and other causes of thyrotoxicosis","volume":"26","author":"Ross DS","year":"2016","unstructured":"Ross DS, Burch HB, Cooper DS, et al.. 2016 American Thyroid Association guidelines for diagnosis and management of hyperthyroidism and other causes of thyrotoxicosis. Thyroid. 2016, 26:1343-421. 10.1089\/thy.2016.0229","journal-title":"Thyroid"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.1186\/s12245-024-00783-2","article-title":"Plasma exchange as a rescue therapy for treatment-resistant thyroid storm with concurrent heart failure: a literature review based on a case report","volume":"17","author":"Ebrahimi P","year":"2024","unstructured":"Ebrahimi P, Payab M, Taheri M, et al.. Plasma exchange as a rescue therapy for treatment-resistant thyroid storm with concurrent heart failure: a literature review based on a case report. Int J Emerg Med. 2024, 17:195. 10.1186\/s12245-024-00783-2","journal-title":"Int J Emerg Med"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.7759\/cureus.98315","article-title":"Treatment of severe thyrotoxicosis with therapeutic plasma exchange in a patient with a methimazole adverse reaction","volume":"17","author":"Buryk Y","year":"2025","unstructured":"Buryk Y, Arteaga C, Magdal LE, DiMarco JT, Akinsete OT. Treatment of severe thyrotoxicosis with therapeutic plasma exchange in a patient with a methimazole adverse reaction. Cureus. 2025, 17:e98315. 10.7759\/cureus.98315","journal-title":"Cureus"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.1007\/s12020-025-04314-8","article-title":"Therapeutic plasmapheresis in the management of thyrotoxicosis: a-retrospective study with emphasis on critically ill patients","volume":"90","author":"Mutlu U","year":"2025","unstructured":"Mutlu U, Bektas F, Dadin S, et al.. Therapeutic plasmapheresis in the management of thyrotoxicosis: a-retrospective study with emphasis on critically ill patients. Endocrine. 2025, 90:157-65. 10.1007\/s12020-025-04314-8","journal-title":"Endocrine"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.21037\/apm-20-190","article-title":"Plasmapheresis in the treatment of multi-drug intoxication involving levothyroxine sodium and calcium channel blockers: a case report","volume":"10","author":"Li R","year":"2021","unstructured":"Li R, Xu YW, Xue Y, Wu XZ. Plasmapheresis in the treatment of multi-drug intoxication involving levothyroxine sodium and calcium channel blockers: a case report. Ann Palliat Med. 2021, 10:5839-45. 10.21037\/apm-20-190","journal-title":"Ann Palliat Med"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.1017\/cem.2014.75","article-title":"Case report: clues to the diagnosis of an unsuspected massive levothyroxine overdose","volume":"17","author":"Allen KM","year":"2015","unstructured":"Allen KM, Crawford VB, Conaglen JV, Elston MS. Case report: clues to the diagnosis of an unsuspected massive levothyroxine overdose. CJEM. 2015, 17:692-8. 10.1017\/cem.2014.75","journal-title":"CJEM"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.7759\/cureus.36172","article-title":"Suicide attempt with levothyroxine overdose","volume":"15","author":"Gill AS","year":"2023","unstructured":"Gill AS, Rai HK, Karunakaran A, Chaudhuri A. Suicide attempt with levothyroxine overdose. Cureus. 2023, 15:e36172. 10.7759\/cureus.36172","journal-title":"Cureus"},{"key":"ref8","article-title":"A review of the pharmacokinetics of levothyroxine for the treatment of hypothyroidism","volume":"9","author":"Colucci P","year":"2013","unstructured":"Colucci P, Yue CS, Ducharme M, Benvenga S. A review of the pharmacokinetics of levothyroxine for the treatment of hypothyroidism. Eur Endocrinol. 2013, 9:40-7.","journal-title":"Eur Endocrinol"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.1007\/BF00263555","article-title":"Massive thyroxine intoxication: evaluation of plasma extraction","volume":"13","author":"Binimelis J","year":"1987","unstructured":"Binimelis J, Bassas L, Marruecos L, et al.. Massive thyroxine intoxication: evaluation of plasma extraction. Intensive Care Med. 1987, 13:33-8. 10.1007\/BF00263555","journal-title":"Intensive Care Med"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.1159\/000517175","article-title":"2021 European Thyroid Association guidelines for the management of iodine-based contrast media-induced thyroid dysfunction","volume":"10","author":"Bednarczuk T","year":"2021","unstructured":"Bednarczuk T, Brix TH, Schima W, Zettinig G, Kahaly GJ. 2021 European Thyroid Association guidelines for the management of iodine-based contrast media-induced thyroid dysfunction. Eur Thyroid J. 2021, 10:269-84. 10.1159\/000517175","journal-title":"Eur Thyroid J"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.1089\/thy.1991.1.273","article-title":"Propranolol and thyroid hormone metabolism","volume":"1","author":"Wiersinga WM","year":"1991","unstructured":"Wiersinga WM. Propranolol and thyroid hormone metabolism. Thyroid. 1991, 1:273-7. 10.1089\/thy.1991.1.273","journal-title":"Thyroid"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.1210\/jcem-41-5-911","article-title":"Opposite effects of dexamethasone on serum concentrations of 3,3',5'-triiodothyronine (reverse T3) and 3,3'5-triiodothyronine (T3)","volume":"41","author":"Chopra IJ","year":"1975","unstructured":"Chopra IJ, Williams DE, Orgiazzi J, Solomon DH. Opposite effects of dexamethasone on serum concentrations of 3,3',5'-triiodothyronine (reverse T3) and 3,3'5-triiodothyronine (T3). J Clin Endocrinol Metab. 1975, 41:911-20. 10.1210\/jcem-41-5-911","journal-title":"J Clin Endocrinol Metab"},{"key":"ref13","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2265.1993.tb00970.x","article-title":"Adjunctive cholestyramine therapy for thyrotoxicosis","volume":"38","author":"Solomon BL","year":"1993","unstructured":"Solomon BL, Wartofsky L, Burman KD. Adjunctive cholestyramine therapy for thyrotoxicosis. Clin Endocrinol (Oxf). 1993, 38:39-43. 10.1111\/j.1365-2265.1993.tb00970.x","journal-title":"Clin Endocrinol (Oxf)"},{"key":"ref14","doi-asserted-by":"publisher","DOI":"10.2310\/8000.2011.110361","article-title":"Massive levothyroxine ingestion in a pediatric patient: case report and discussion","volume":"13","author":"Ho J","year":"2011","unstructured":"Ho J, Jackson R, Johnson D. Massive levothyroxine ingestion in a pediatric patient: case report and discussion. CJEM. 2011, 13:165-8. 10.2310\/8000.2011.110361","journal-title":"CJEM"},{"key":"ref15","doi-asserted-by":"publisher","DOI":"10.1177\/000992288902800808","article-title":"Massive levothyroxine ingestion: conservative management","volume":"28","author":"Mandel SH","year":"1989","unstructured":"Mandel SH, Magnusson AR, Burton BT, Swanson JR, LaFranchi SH. Massive levothyroxine ingestion: conservative management. Clin Pediatr (Phila). 1989, 28:374-6. 10.1177\/000992288902800808","journal-title":"Clin Pediatr (Phila)"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/464006-therapeutic-plasma-exchange-for-severe-exogenous-thyrotoxicosis-following-massive-levothyroxine-ingestion-a-case-report","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,3,14]],"date-time":"2026-03-14T03:31:36Z","timestamp":1773459096000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/464006-therapeutic-plasma-exchange-for-severe-exogenous-thyrotoxicosis-following-massive-levothyroxine-ingestion-a-case-report"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,3,13]]},"references-count":15,"URL":"https:\/\/doi.org\/10.7759\/cureus.105194","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2026,3,13]]}}}